{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:11:43Z","timestamp":1790881903420,"version":"4.1.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T00:00:00Z","timestamp":1523059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["1U01AR069869-01"],"award-info":[{"award-number":["1U01AR069869-01"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00198-018-4507-8","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T03:06:26Z","timestamp":1523070386000},"page":"1009-1022","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Anabolic agents: what is beyond osteoporosis?"],"prefix":"10.1007","volume":"29","author":[{"given":"Y.","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. E.","family":"Levack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Marty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Samuels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Redko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. M.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,7]]},"reference":[{"key":"4507_CR1","doi-asserted-by":"publisher","first-page":"ITC17","DOI":"10.7326\/AITC201708010","volume":"167","author":"KE Ensrud","year":"2017","unstructured":"Ensrud KE, Crandall CJ (2017) Osteoporosis. Ann Intern Med 167:ITC17\u2013ITC32","journal-title":"Ann Intern Med"},{"key":"4507_CR2","doi-asserted-by":"publisher","first-page":"46","DOI":"10.5152\/eurjrheum.2016.048","volume":"4","author":"T Sozen","year":"2017","unstructured":"Sozen T, Ozisik L, Basaran NC (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46\u201356","journal-title":"Eur J Rheumatol"},{"key":"4507_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.maturitas.2016.12.003","volume":"97","author":"CK Chew","year":"2017","unstructured":"Chew CK, Clarke BL (2017) Abaloparatide: recombinant human PTHrP (1-34) anabolic therapy for osteoporosis. Maturitas 97:53\u201360","journal-title":"Maturitas"},{"key":"4507_CR4","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA, Dalsky GP, Marcus R (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357:2028\u20132039","journal-title":"N Engl J Med"},{"key":"4507_CR5","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMra067395","volume":"357","author":"E Canalis","year":"2007","unstructured":"Canalis E, Giustina A, Bilezikian JP (2007) Mechanisms of anabolic therapies for osteoporosis. N Engl J Med 357:905\u2013916","journal-title":"N Engl J Med"},{"key":"4507_CR6","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1210\/en.2015-1726","volume":"157","author":"G Hattersley","year":"2016","unstructured":"Hattersley G, Dean T, Corbin BA, Bahar H, Gardella TJ (2016) Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling. Endocrinology 157:141\u2013149","journal-title":"Endocrinology"},{"key":"4507_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1001\/jama.2016.11136","volume":"316","author":"PD Miller","year":"2016","unstructured":"Miller PD, Hattersley G, Riis BJ, Williams GC, Lau E, Russo LA, Alexandersen P, Zerbini CAF, Hu MY, Harris AG, Fitzpatrick LA, Cosman F, Christiansen C, for the ACTIVE Study Investigators (2016) Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial. JAMA 316:722\u2013733","journal-title":"JAMA"},{"key":"4507_CR8","first-page":"1585","volume-title":"Lancet","author":"BL Langdahl","year":"2017","unstructured":"Langdahl BL, Libanati C, Crittenden DB, Bolognese MA, Brown JP, Daizadeh NS, Dokoupilova E, Engelke K, Finkelstein JS, Genant HK, Goemaere S, Hyldstrup L, Jodar-Gimeno E, Keaveny TM, Kendler D, Lakatos P, Maddox J, Malouf J, Massari FE, Molina JF, Ulla MR, Grauer A (2017) Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial. In: Lancet, vol 390, pp 1585\u20131594"},{"key":"4507_CR9","doi-asserted-by":"crossref","unstructured":"Saag KG, Petersen J, Brandi ML, Karaplis AC, Lorentzon M, Thomas T, Maddox J, Fan M, Meisner PD, Grauer A (2017) Romosozumab or alendronate for fracture prevention in women with osteoporosis. N Engl J Med","DOI":"10.1056\/NEJMoa1708322"},{"key":"4507_CR10","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.wneu.2016.11.135","volume":"100","author":"N Chaudhary","year":"2017","unstructured":"Chaudhary N, Lee JS, Wu JY, Tharin S (2017) Evidence for use of teriparatide in spinal fusion surgery in osteoporotic patients. World Neurosurg 100:551\u2013556","journal-title":"World Neurosurg"},{"key":"4507_CR11","doi-asserted-by":"crossref","unstructured":"Yishake M, Yasen M, Jiang L, Liu W, Xing R, Chen Q, Lin H, Dong J (2017) Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia. J Orthop Res","DOI":"10.1002\/jor.23682"},{"key":"4507_CR12","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.spinee.2014.08.001","volume":"15","author":"T Sugiura","year":"2015","unstructured":"Sugiura T, Kashii M, Matsuo Y, Morimoto T, Honda H, Kaito T, Iwasaki M, Yoshikawa H (2015) Intermittent administration of teriparatide enhances graft bone healing and accelerates spinal fusion in rats with glucocorticoid-induced osteoporosis. Spine J 15:298\u2013306","journal-title":"Spine J"},{"key":"4507_CR13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/BRS.0000000000000169","volume":"39","author":"IA Lina","year":"2014","unstructured":"Lina IA, Puvanesarajah V, Liauw JA et al (2014) Quantitative study of parathyroid hormone (1-34) and bone morphogenetic protein-2 on spinal fusion outcomes in a rabbit model of lumbar dorsolateral intertransverse process arthrodesis. Spine (Phila Pa 1976) 39:347\u2013355","journal-title":"Spine (Phila Pa 1976)"},{"key":"4507_CR14","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1007\/s00198-013-2385-7","volume":"24","author":"Z Qiu","year":"2013","unstructured":"Qiu Z, Wei L, Liu J, Sochacki KR, Liu X, Bishop C, Ebraheim M, Yang H (2013) Effect of intermittent PTH (1-34) on posterolateral spinal fusion with iliac crest bone graft in an ovariectomized rat model. Osteoporos Int 24:2693\u20132700","journal-title":"Osteoporos Int"},{"key":"4507_CR15","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1097\/BRS.0b013e31824ac089","volume":"37","author":"N Ming","year":"2012","unstructured":"Ming N, Cheng JT, Rui YF, Chan KM, Kuhstoss S, Ma YL, Sato M, Wang Y, Li G (2012) Dose-dependent enhancement of spinal fusion in rats with teriparatide (PTH[1\u201334]). Spine (Phila Pa 1976) 37:1275\u20131282","journal-title":"Spine (Phila Pa 1976)"},{"key":"4507_CR16","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/BRS.0b013e3181b71a96","volume":"35","author":"RA Lehman Jr","year":"2010","unstructured":"Lehman RA Jr, Dmitriev AE, Cardoso MJ, Helgeson MD, Christensen CL, Raymond JW, Eckel TT, Riew KD (2010) Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model. Spine (Phila Pa 1976) 35:146\u2013152","journal-title":"Spine (Phila Pa 1976)"},{"key":"4507_CR17","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/BRS.0b013e318191e687","volume":"34","author":"PF O'Loughlin","year":"2009","unstructured":"O'Loughlin PF, Cunningham ME, Bukata SV, Tomin E, Poynton AR, Doty SB, Sama AA, Lane JM (2009) Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model. Spine (Phila Pa 1976) 34:121\u2013130","journal-title":"Spine (Phila Pa 1976)"},{"key":"4507_CR18","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.bone.2007.06.025","volume":"41","author":"Y Abe","year":"2007","unstructured":"Abe Y, Takahata M, Ito M, Irie K, Abumi K, Minami A (2007) Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model. Bone 41:775\u2013785","journal-title":"Bone"},{"key":"4507_CR19","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.spinee.2005.10.010","volume":"6","author":"JP Lawrence","year":"2006","unstructured":"Lawrence JP, Ennis F, White AP, Magit D, Polzhofer G, Drespe I, Troiano NW, Grauer JN (2006) Effect of daily parathyroid hormone (1-34) on lumbar fusion in a rat model. Spine J 6:385\u2013390","journal-title":"Spine J"},{"key":"4507_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.joms.2015.07.005","volume":"74","author":"A Keskinruzgar","year":"2016","unstructured":"Keskinruzgar A, Bozdag Z, Aras MH, Demir T, Yolcu U, Cetiner S (2016) Histopathological effects of teriparatide in medication-related osteonecrosis of the jaw: an animal study. J Oral Maxillofac Surg 74:68\u201378","journal-title":"J Oral Maxillofac Surg"},{"key":"4507_CR21","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.ijom.2013.05.001","volume":"42","author":"EH Dayisoylu","year":"2013","unstructured":"Dayisoylu EH, Senel FC, Ungor C, Tosun E, Cankaya M, Ersoz S, Taskesen F (2013) The effects of adjunctive parathyroid hormone injection on bisphosphonate-related osteonecrosis of the jaws: an animal study. Int J Oral Maxillofac Surg 42:1475\u20131480","journal-title":"Int J Oral Maxillofac Surg"},{"key":"4507_CR22","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1007\/s00223-010-9458-9","volume":"88","author":"H Daugaard","year":"2011","unstructured":"Daugaard H, Elmengaard B, Andreassen T, Bechtold J, Lamberg A, Soballe K (2011) Parathyroid hormone treatment increases fixation of orthopedic implants with gap healing: a biomechanical and histomorphometric canine study of porous coated titanium alloy implants in cancellous bone. Calcif Tissue Int 88:294\u2013303","journal-title":"Calcif Tissue Int"},{"key":"4507_CR23","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00198-012-2258-5","volume":"24","author":"YF Li","year":"2013","unstructured":"Li YF, Li XD, Bao CY, Chen QM, Zhang H, Hu J (2013) Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Osteoporos Int 24:1063\u20131071","journal-title":"Osteoporos Int"},{"key":"4507_CR24","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1359\/jbmr.2002.17.11.2038","volume":"17","author":"A Nakajima","year":"2002","unstructured":"Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M (2002) Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 17:2038\u20132047","journal-title":"J Bone Miner Res"},{"key":"4507_CR25","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1359\/jbmr.1999.14.6.960","volume":"14","author":"TT Andreassen","year":"1999","unstructured":"Andreassen TT, Ejersted C, Oxlund H (1999) Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res 14:960\u2013968","journal-title":"J Bone Miner Res"},{"key":"4507_CR26","first-page":"731","volume":"87","author":"YM Alkhiary","year":"2005","unstructured":"Alkhiary YM, Gerstenfeld LC, Krall E, Westmore M, Sato M, Mitlak BH, Einhorn TA (2005) Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 87:731\u2013741","journal-title":"J Bone Joint Surg Am"},{"key":"4507_CR27","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.bone.2007.01.015","volume":"40","author":"T Manabe","year":"2007","unstructured":"Manabe T, Mori S, Mashiba T, Kaji Y, Iwata K, Komatsubara S, Seki A, Sun YX, Yamamoto T (2007) Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone 40:1475\u20131482","journal-title":"Bone"},{"key":"4507_CR28","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.bone.2009.11.009","volume":"46","author":"M Tagil","year":"2010","unstructured":"Tagil M, McDonald MM, Morse A, Peacock L, Mikulec K, Amanat N, Godfrey C, Little DG (2010) Intermittent PTH(1-34) does not increase union rates in open rat femoral fractures and exhibits attenuated anabolic effects compared to closed fractures. Bone 46:852\u2013859","journal-title":"Bone"},{"key":"4507_CR29","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.bone.2008.07.251","volume":"43","author":"EF Morgan","year":"2008","unstructured":"Morgan EF, Mason ZD, Bishop G, Davis AD, Wigner NA, Gerstenfeld LC, Einhorn TA (2008) Combined effects of recombinant human BMP-7 (rhBMP-7) and parathyroid hormone (1-34) in metaphyseal bone healing. Bone 43:1031\u20131038","journal-title":"Bone"},{"key":"4507_CR30","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s13287-017-0502-9","volume":"8","author":"D Cohn Yakubovich","year":"2017","unstructured":"Cohn Yakubovich D, Sheyn D, Bez M, Schary Y, Yalon E, Sirhan A, Amira M, Yaya A, de Mel S, da X, Ben-David S, Tawackoli W, Ley EJ, Gazit D, Gazit Z, Pelled G (2017) Systemic administration of mesenchymal stem cells combined with parathyroid hormone therapy synergistically regenerates multiple rib fractures. Stem Cell Res Ther 8:51","journal-title":"Stem Cell Res Ther"},{"key":"4507_CR31","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00198-011-1751-6","volume":"23","author":"YF Li","year":"2012","unstructured":"Li YF, Zhou CC, Li JH, Luo E, Zhu SS, Feng G, Hu J (2012) The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. Osteoporos Int 23:1463\u20131474","journal-title":"Osteoporos Int"},{"key":"4507_CR32","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.bone.2010.05.013","volume":"47","author":"M Komrakova","year":"2010","unstructured":"Komrakova M, Stuermer EK, Werner C, Wicke M, Kolios L, Sehmisch S, Tezval M, Daub F, Martens T, Witzenhausen P, Dullin C, Stuermer KM (2010) Effect of human parathyroid hormone hPTH (1-34) applied at different regimes on fracture healing and muscle in ovariectomized and healthy rats. Bone 47:480\u2013492","journal-title":"Bone"},{"key":"4507_CR33","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/BOT.0b013e31826f5b9e","volume":"26","author":"EA Lin","year":"2012","unstructured":"Lin EA, Liu CJ, Monroy A, Khurana S, Egol KA (2012) Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model. J Orthop Trauma 26:719\u2013723","journal-title":"J Orthop Trauma"},{"key":"4507_CR34","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bone.2010.05.015","volume":"47","author":"AV Sloan","year":"2010","unstructured":"Sloan AV, Martin JR, Li S, Li J (2010) Parathyroid hormone and bisphosphonate have opposite effects on stress fracture repair. Bone 47:235\u2013240","journal-title":"Bone"},{"key":"4507_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.4184\/asj.2017.11.2.272","volume":"11","author":"S Ohtori","year":"2017","unstructured":"Ohtori S, Orita S, Yamauchi K, Eguchi Y, Aoki Y, Nakamura J, Suzuki M, Kubota G, Inage K, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue M, Kinoshita H, Furuya T, Koda M (2017) Does discontinuing teriparatide treatment and replacing it with bisphosphonate maintain the volume of the bone fusion mass after lumbar posterolateral fusion in women with postmenopausal osteoporosis? Asian Spine J 11:272\u2013277","journal-title":"Asian Spine J"},{"key":"4507_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005996","volume":"96","author":"AK Kaliya-Perumal","year":"2017","unstructured":"Kaliya-Perumal AK, Lu ML, Luo CA, Tsai TT, Lai PL, Chen LH, Chen WJ, Niu CC (2017) Retrospective radiological outcome analysis following teriparatide use in elderly patients undergoing multilevel instrumented lumbar fusion surgery. Medicine (Baltimore) 96:e5996","journal-title":"Medicine (Baltimore)"},{"key":"4507_CR37","doi-asserted-by":"publisher","first-page":"573","DOI":"10.4184\/asj.2015.9.4.573","volume":"9","author":"S Ohtori","year":"2015","unstructured":"Ohtori S, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kuniyoshi K, Aoki Y, Nakamura J, Miyagi M, Suzuki M, Kubota G, Inage K, Sainoh T, Sato J, Shiga Y, Abe K, Fujimoto K, Kanamoto H, Inoue G, Takahashi K (2015) More than 6 months of teriparatide treatment was more effective for bone union than shorter treatment following lumbar posterolateral fusion surgery. Asian Spine J 9:573\u2013580","journal-title":"Asian Spine J"},{"key":"4507_CR38","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3171\/2014.5.SPINE13656","volume":"21","author":"G Inoue","year":"2014","unstructured":"Inoue G, Ueno M, Nakazawa T, Imura T, Saito W, Uchida K, Ohtori S, Toyone T, Takahira N, Takaso M (2014) Teriparatide increases the insertional torque of pedicle screws during fusion surgery in patients with postmenopausal osteoporosis. J Neurosurg Spine 21:425\u2013431","journal-title":"J Neurosurg Spine"},{"key":"4507_CR39","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00586-015-4342-y","volume":"26","author":"PG Cho","year":"2017","unstructured":"Cho PG, Ji GY, Shin DA, Ha Y, Yoon DH, Kim KN (2017) An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data. Eur Spine J 26:691\u2013697","journal-title":"Eur Spine J"},{"key":"4507_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2106\/JBJS.16.00230","volume":"99","author":"S Ebata","year":"2017","unstructured":"Ebata S, Takahashi J, Hasegawa T, Mukaiyama K, Isogai Y, Ohba T, Shibata Y, Ojima T, Yamagata Z, Matsuyama Y, Haro H (2017) Role of weekly teriparatide administration in osseous union enhancement within six months after posterior or transforaminal lumbar interbody fusion for osteoporosis-associated lumbar degenerative disorders: a multicenter, prospective randomized study. J Bone Joint Surg Am 99:365\u2013372","journal-title":"J Bone Joint Surg Am"},{"key":"4507_CR41","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s00586-017-4959-0","volume":"26","author":"S Seki","year":"2017","unstructured":"Seki S, Hirano N, Kawaguchi Y, Nakano M, Yasuda T, Suzuki K, Watanabe K, Makino H, Kanamori M, Kimura T (2017) Teriparatide versus low-dose bisphosphonates before and after surgery for adult spinal deformity in female Japanese patients with osteoporosis. Eur Spine J 26:2121\u20132127","journal-title":"Eur Spine J"},{"key":"4507_CR42","doi-asserted-by":"publisher","first-page":"E487","DOI":"10.1097\/BRS.0b013e31828826dd","volume":"38","author":"S Ohtori","year":"2013","unstructured":"Ohtori S, Inoue G, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Takaso M, Toyone T, Takahashi K (2013) Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective. Spine (Phila Pa 1976) 38:E487\u2013E492","journal-title":"Spine (Phila Pa 1976)"},{"key":"4507_CR43","doi-asserted-by":"publisher","first-page":"E1464","DOI":"10.1097\/BRS.0b013e31826ca2a8","volume":"37","author":"S Ohtori","year":"2012","unstructured":"Ohtori S, Inoue G, Orita S, Yamauchi K, Eguchi Y, Ochiai N, Kishida S, Kuniyoshi K, Aoki Y, Nakamura J, Ishikawa T, Miyagi M, Kamoda H, Suzuki M, Kubota G, Sakuma Y, Oikawa Y, Inage K, Sainoh T, Takaso M, Ozawa T, Takahashi K, Toyone T (2012) Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study. Spine (Phila Pa 1976) 37:E1464\u2013E1468","journal-title":"Spine (Phila Pa 1976)"},{"key":"4507_CR44","doi-asserted-by":"crossref","unstructured":"Jung J, Yoo HY, Kim GT, Lee JW, Lee YA, Kim DY, Kwon YD (2017) Short-term teriparatide and recombinant human bone morphogenetic protein-2 for regenerative approach to medication-related osteonecrosis of the jaw: a preliminary study. J Bone Miner Res","DOI":"10.1002\/jbmr.3237"},{"key":"4507_CR45","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","volume":"25","author":"KM Kim","year":"2014","unstructured":"Kim KM, Park W, Oh SY, Kim HJ, Nam W, Lim SK, Rhee Y, Cha IH (2014) Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw. Osteoporos Int 25:1625\u20131632","journal-title":"Osteoporos Int"},{"key":"4507_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1177\/230949901602400106","volume":"24","author":"T Kaneko","year":"2016","unstructured":"Kaneko T, Otani T, Kono N, Mochizuki Y, Mori T, Nango N, Ikegami H, Musha Y (2016) Weekly injection of teriparatide for bone ingrowth after cementless total knee arthroplasty. J Orthop Surg (Hong Kong) 24:16\u201321","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"4507_CR47","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s12891-016-1149-x","volume":"17","author":"TW Huang","year":"2016","unstructured":"Huang TW, Huang KC, Lin SJ, Chuang PY, Shih HN, Lee MS, Hsu RW, Shen WJ (2016) Effects of teriparatide on cementless bipolar hemiarthroplasty in patients with osteoporotic femoral neck fractures. BMC Musculoskelet Disord 17:300","journal-title":"BMC Musculoskelet Disord"},{"key":"4507_CR48","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.arth.2015.07.017","volume":"31","author":"N Kobayashi","year":"2016","unstructured":"Kobayashi N, Inaba Y, Uchiyama M, Ike H, Kubota S, Saito T (2016) Teriparatide versus alendronate for the preservation of bone mineral density after Total hip arthroplasty\u2014a randomized controlled trial. J Arthroplast 31:333\u2013338","journal-title":"J Arthroplast"},{"key":"4507_CR49","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/17453674.2017.1300745","volume":"88","author":"H Ledin","year":"2017","unstructured":"Ledin H, Good L, Johansson T, Aspenberg P (2017) No effect of teriparatide on migration in total knee replacement. Acta Orthop 88:259\u2013262","journal-title":"Acta Orthop"},{"key":"4507_CR50","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1359\/jbmr.090731","volume":"25","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Genant HK, Johansson T, Nino AJ, See K, Krohn K, Garc\u00eda-Hern\u00e1ndez PA, Recknor CP, Einhorn TA, Dalsky GP, Mitlak BH, Fierlinger A, Lakshmanan MC (2010) Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 25:404\u2013414","journal-title":"J Bone Miner Res"},{"key":"4507_CR51","doi-asserted-by":"publisher","first-page":"234","DOI":"10.3109\/17453671003761946","volume":"81","author":"P Aspenberg","year":"2010","unstructured":"Aspenberg P, Johansson T (2010) Teriparatide improves early callus formation in distal radial fractures. Acta Orthop 81:234\u2013236","journal-title":"Acta Orthop"},{"key":"4507_CR52","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.2106\/JBJS.J.01379","volume":"93","author":"P Peichl","year":"2011","unstructured":"Peichl P, Holzer LA, Maier R, Holzer G (2011) Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women. J Bone Joint Surg Am 93:1583\u20131587","journal-title":"J Bone Joint Surg Am"},{"key":"4507_CR53","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.semarthrit.2014.09.005","volume":"44","author":"PD Miller","year":"2015","unstructured":"Miller PD, McCarthy EF (2015) Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration. Semin Arthritis Rheum 44:477\u2013482","journal-title":"Semin Arthritis Rheum"},{"key":"4507_CR54","doi-asserted-by":"publisher","first-page":"148","DOI":"10.5371\/hp.2016.28.3.148","volume":"28","author":"JT Kim","year":"2016","unstructured":"Kim JT, Jeong HJ, Lee SJ, Kim HJ, Yoo JJ (2016) Adjuvant teriparatide therapy for surgical treatment of femoral fractures; does it work? Hip Pelvis 28:148\u2013156","journal-title":"Hip Pelvis"},{"key":"4507_CR55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00774-014-0617-3","volume":"33","author":"N Miyakoshi","year":"2015","unstructured":"Miyakoshi N, Aizawa T, Sasaki S, Ando S, Maekawa S, Aonuma H, Tsuchie H, Sasaki H, Kasukawa Y, Shimada Y (2015) Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide. J Bone Miner Metab 33:553\u2013559","journal-title":"J Bone Miner Metab"},{"key":"4507_CR56","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/jbmr.3081","volume":"32","author":"NB Watts","year":"2017","unstructured":"Watts NB, Aggers D, McCarthy EF, Savage T, Martinez S, Patterson R, Carrithers E, Miller PD (2017) Responses to treatment with teriparatide in patients with atypical femur fractures previously treated with bisphosphonates. J Bone Miner Res 32:1027\u20131033","journal-title":"J Bone Miner Res"},{"key":"4507_CR57","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.bone.2012.10.006","volume":"52","author":"CY Chiang","year":"2013","unstructured":"Chiang CY, Zebaze RM, Ghasem-Zadeh A, Iuliano-Burns S, Hardidge A, Seeman E (2013) Teriparatide improves bone quality and healing of atypical femoral fractures associated with bisphosphonate therapy. Bone 52:360\u2013365","journal-title":"Bone"},{"key":"4507_CR58","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1007\/s00198-012-2172-x","volume":"23","author":"YK Lee","year":"2012","unstructured":"Lee YK, Ha YC, Koo KH (2012) Teriparatide, a nonsurgical solution for femoral nonunion? A report of three cases. Osteoporos Int 23:2897\u20132900","journal-title":"Osteoporos Int"},{"key":"4507_CR59","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000006571","volume":"96","author":"L Xiaofeng","year":"2017","unstructured":"Xiaofeng L, Daxia X, Yunzhen C (2017) Teriparatide as a nonoperative treatment for tibial and femoral fracture nonunion: a case report. Medicine (Baltimore) 96:e6571","journal-title":"Medicine (Baltimore)"},{"key":"4507_CR60","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijscr.2017.08.001","volume":"39","author":"C Emanuele","year":"2017","unstructured":"Emanuele C, Leonardo P, Gianfilippo C, Matteo A, Doria C (2017) Peri-prosthetic humeral non-union: where biology meets bio-mechanic. A case report. Int J Surg Case Rep 39:102\u2013105","journal-title":"Int J Surg Case Rep"},{"key":"4507_CR61","doi-asserted-by":"publisher","first-page":"E319","DOI":"10.1097\/BSD.0b013e31828d6c88","volume":"26","author":"DA Bednar","year":"2013","unstructured":"Bednar DA (2013) Teriparatide treatment of a glucocorticoid-associated resorbing nonunion of a type III odontoid process fracture: a case report. J Spinal Disord Tech 26:E319\u2013E322","journal-title":"J Spinal Disord Tech"},{"key":"4507_CR62","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4137\/CMED.S9663","volume":"5","author":"P Raghavan","year":"2012","unstructured":"Raghavan P, Christofides E (2012) Role of teriparatide in accelerating metatarsal stress fracture healing: a case series and review of literature. Clin Med Insights Endocrinol Diabetes 5:39\u201345","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"4507_CR63","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1210\/jc.2006-1902","volume":"92","author":"MP Whyte","year":"2007","unstructured":"Whyte MP, Mumm S, Deal C (2007) Adult hypophosphatasia treated with teriparatide. J Clin Endocrinol Metab 92:1203\u20131208","journal-title":"J Clin Endocrinol Metab"},{"key":"4507_CR64","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1359\/jbmr.2003.18.3.539","volume":"18","author":"JR Zanchetta","year":"2003","unstructured":"Zanchetta JR, Bogado CE, Ferretti JL, Wang O, Wilson MG, Sato M, Gaich GA, Dalsky GP, Myers SL (2003) Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis. J Bone Miner Res 18:539\u2013543","journal-title":"J Bone Miner Res"},{"key":"4507_CR65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00223-010-9386-8","volume":"87","author":"R Schnell","year":"2010","unstructured":"Schnell R, Graeff C, Krebs A, Oertel H, Gluer CC (2010) Changes in cross-sectional area of spinal canal and vertebral body under 2 years of teriparatide treatment: results from the EUROFORS study. Calcif Tissue Int 87:130\u2013136","journal-title":"Calcif Tissue Int"},{"key":"4507_CR66","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1056\/NEJMc1002684","volume":"363","author":"A Cheung","year":"2010","unstructured":"Cheung A, Seeman E (2010) Teriparatide therapy for alendronate-associated osteonecrosis of the jaw. N Engl J Med 363:2473\u20132474","journal-title":"N Engl J Med"},{"issue":"584\u2013594","key":"4507_CR67","volume":"148","author":"M El-Rabbany","year":"2017","unstructured":"El-Rabbany M, Sgro A, Lam DK, Shah PS, Azarpazhooh A (2017) Effectiveness of treatments for medication-related osteonecrosis of the jaw: a systematic review and meta-analysis. J Am Dent Assoc 148(584\u2013594):e582","journal-title":"J Am Dent Assoc"},{"key":"4507_CR68","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1007\/s00198-013-2277-x","volume":"24","author":"D Yoshiga","year":"2013","unstructured":"Yoshiga D, Yamashita Y, Nakamichi I, Tanaka T, Yamauchi K, Yamamoto N, Nogami S, Kaneuji T, Mitsugi S, Sakurai T, Kiyomiya H, Tominaga K, Morimoto Y, Takahashi T (2013) Weekly teriparatide injections successfully treated advanced bisphosphonate-related osteonecrosis of the jaws. Osteoporos Int 24:2365\u20132369","journal-title":"Osteoporos Int"},{"key":"4507_CR69","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1056\/NEJMoa1005361","volume":"363","author":"JD Bashutski","year":"2010","unstructured":"Bashutski JD, Eber RM, Kinney JS, Benavides E, Maitra S, Braun TM, Giannobile WV, McCauley LK (2010) Teriparatide and osseous regeneration in the oral cavity. N Engl J Med 363:2396\u20132405","journal-title":"N Engl J Med"},{"key":"4507_CR70","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan AA, Morrison A, Hanley DA, Felsenberg D, McCauley LK, O'Ryan F, Reid IR, Ruggiero SL, Taguchi A, Tetradis S, Watts NB, Brandi ML, Peters E, Guise T, Eastell R, Cheung AM, Morin SN, Masri B, Cooper C, Morgan SL, Obermayer-Pietsch B, Langdahl BL, al Dabagh R, Davison KS, Kendler DL, S\u00e1ndor GK, Josse RG, Bhandari M, el Rabbany M, Pierroz DD, Sulimani R, Saunders DP, Brown JP, Compston J, on behalf of the International Task Force on Osteonecrosis of the Jaw (2015) Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 30:3\u201323","journal-title":"J Bone Miner Res"},{"key":"4507_CR71","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s00198-009-1004-0","volume":"21","author":"V Subbiah","year":"2010","unstructured":"Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA (2010) Of mice and men: divergent risks of teriparatide-induced osteosarcoma. Osteoporos Int 21:1041\u20131045","journal-title":"Osteoporos Int"},{"key":"4507_CR72","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.3928\/01477447-20110714-50","volume":"34","author":"A Oteo-Alvaro","year":"2011","unstructured":"Oteo-Alvaro A, Matas JA, Alonso-Farto JC (2011) Teriparatide (rh [1-34] PTH) improved osteointegration of a hemiarthroplasty with signs of aseptic loosening. Orthopedics 34:e574\u2013e577","journal-title":"Orthopedics"},{"key":"4507_CR73","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3899\/jrheum.100980","volume":"38","author":"A Zati","year":"2011","unstructured":"Zati A, Sarti D, Malaguti MC, Pratelli L (2011) Teriparatide in the treatment of a loose hip prosthesis. J Rheumatol 38:778\u2013780","journal-title":"J Rheumatol"},{"key":"4507_CR74","first-page":"32","volume":"7","author":"T Suzuki","year":"2017","unstructured":"Suzuki T, Ryu K, Kojima K, Saito S, Nagaoka H, Tokuhashi Y (2017) Teriparatide treatment improved loosening of cementless total knee arthroplasty: a case report. J Orthop Case Rep 7:32\u201335","journal-title":"J Orthop Case Rep"},{"key":"4507_CR75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrrheum.2014.164","volume":"11","author":"TA Einhorn","year":"2015","unstructured":"Einhorn TA, Gerstenfeld LC (2015) Fracture healing: mechanisms and interventions. Nat Rev Rheumatol 11:45\u201354","journal-title":"Nat Rev Rheumatol"},{"key":"4507_CR76","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1359\/jbmr.070724","volume":"22","author":"S Kakar","year":"2007","unstructured":"Kakar S, Einhorn TA, Vora S, Miara LJ, Hon G, Wigner NA, Toben D, Jacobsen KA, al-Sebaei MO, Song M, Trackman PC, Morgan EF, Gerstenfeld LC, Barnes GL (2007) Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 22:1903\u20131912","journal-title":"J Bone Miner Res"},{"key":"4507_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MCH, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29:1\u201323","journal-title":"J Bone Miner Res"},{"key":"4507_CR78","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1210\/jc.2010-2520","volume":"96","author":"SJ Gomberg","year":"2011","unstructured":"Gomberg SJ, Wustrack RL, Napoli N, Arnaud CD, Black DM (2011) Teriparatide, vitamin D, and calcium healed bilateral subtrochanteric stress fractures in a postmenopausal woman with a 13-year history of continuous alendronate therapy. J Clin Endocrinol Metab 96:1627\u20131632","journal-title":"J Clin Endocrinol Metab"},{"key":"4507_CR79","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1210\/jc.2011-0593","volume":"96","author":"NN Carvalho","year":"2011","unstructured":"Carvalho NN, Voss LA, Almeida MO, Salgado CL, Bandeira F (2011) Atypical femoral fractures during prolonged use of bisphosphonates: short-term responses to strontium ranelate and teriparatide. J Clin Endocrinol Metab 96:2675\u20132680","journal-title":"J Clin Endocrinol Metab"},{"key":"4507_CR80","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.bone.2011.09.042","volume":"49","author":"CK Tjhia","year":"2011","unstructured":"Tjhia CK, Odvina CV, Rao DS, Stover SM, Wang X, Fyhrie DP (2011) Mechanical property and tissue mineral density differences among severely suppressed bone turnover (SSBT) patients, osteoporotic patients, and normal subjects. Bone 49:1279\u20131289","journal-title":"Bone"},{"key":"4507_CR81","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1056\/NEJMra053077","volume":"354","author":"E Seeman","year":"2006","unstructured":"Seeman E, Delmas PD (2006) Bone quality\u2014the material and structural basis of bone strength and fragility. N Engl J Med 354:2250\u20132261","journal-title":"N Engl J Med"},{"key":"4507_CR82","first-page":"525","volume":"102","author":"CA Moreira","year":"2017","unstructured":"Moreira CA, Bilezikian JP (2017) Stress fractures: concepts and therapeutics. J Clin Endocrinol Metab 102:525\u2013534","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-018-4507-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4507-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-018-4507-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,18]],"date-time":"2022-08-18T14:38:55Z","timestamp":1660833535000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-018-4507-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,7]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["4507"],"URL":"https:\/\/doi.org\/10.1007\/s00198-018-4507-8","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,7]]},"assertion":[{"value":"2 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Joseph Lane is a co-principal investigator for a trial of teriparatide and pelvic fracture (NIH: 1U01AR069869-01). Ashley E. Levack is supported by NIH T32 AR007281. Yi Liu, Eric Marty, Omer Or, Blossom P. Samuels, and Mariya Redko declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}